Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGG492 in Chronic Subjective Tinnitus
NCT01302873Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of selurampanel in tinnitus, sponsored by Novartis. Started Jan 2011; status: completed.
02
Drugs
selurampanel
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT01302873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01302873.